Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2025)

enVVeno Medical has reported Cash from Financing Activities over the past 4 years, most recently at $6.3 million for Q4 2020.

  • For Q4 2020, Cash from Financing Activities changed N/A year-over-year to $6.3 million; the TTM value through Dec 2020 reached $15.1 million, up 167.43%, while the annual FY2025 figure was $1.0 million, 92.5% down from the prior year.
  • Cash from Financing Activities for Q4 2020 was $6.3 million at enVVeno Medical, up from $5.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $7.2 million in Q2 2018 and troughed at $570341.0 in Q1 2020.
  • A 4-year average of $3.2 million and a median of $2.3 million in 2019 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: increased 24.8% in 2019 and later plummeted 75.39% in 2020.
  • Year by year, Cash from Financing Activities stood at $968352.0 in 2017, then skyrocketed by 640.88% to $7.2 million in 2018, then plummeted by 53.73% to $3.3 million in 2019, then surged by 91.19% to $6.3 million in 2020.
  • Business Quant data shows Cash from Financing Activities for NVNO at $6.3 million in Q4 2020, $5.9 million in Q3 2020, and $2.3 million in Q2 2020.